Chemical Control System of Epigenetics

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Epigenetics refers to heritable gene expression changes without DNA sequence alteration.
• Environmental factors can disrupt epigenetic regulation, leading to diseases like cancer and neurodegeneration.
• Bioinformatics has identified structural modifications in epigenetic enzymes linked to complex diseases.

Purpose of the Study:

• To summarize the chemical aspects of natural epigenetic control.
• To detail recent advances in synthetic strategies for mimicking genetic and epigenetic control.
• To highlight the development of small-molecule inhibitors ('epi-drugs') for therapeutic applications.

Main Methods:

• Review of contemporary bioinformatics tools for analyzing epigenetic enzyme modifications.
• Analysis of synthetic strategies for developing small-molecule inhibitors.
• Examination of recent advancements in biomimetic epigenetic code development.

Main Results:

• Identification of structural chemical modifications in epigenetic enzymes associated with diseases.
• Development of synthetic small-molecule inhibitors targeting epigenetic enzymes.
• Emergence of artificial biomimetic epigenetic codes combining modifiers and DNA-binding molecules.

Conclusions:

• Epigenetic dysregulation is implicated in various complex diseases.
• Small-molecule inhibitors ('epi-drugs') show therapeutic potential but face clinical barriers.
• Synthetic strategies are advancing to mimic natural epigenetic control for novel therapeutic approaches.